Sepset Biosciences

Business Services · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

2405 Wesbrook Mall Fl 4, Vancouver, Brit...

Phone Number

(778) 846-5406

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Sepset Biosciences

Sepset Biosciences Inc. is a molecular diagnostics company focused on developing a first-in-class diagnostic assay for the early and rapid risk assessment of sepsis. Their innovative assay detects a unique sepsis gene expression signature linked to dysfunctional immune responses, rather than relying on pathogen presence. This technology addresses the significant challenges in current sepsis diagnosis methods, which are often slow and inaccurate, and targets a condition that affects over 49 million people globally each year. With the high costs associated with sepsis treatment, their solution has substantial commercial potential, although it has not yet received marketing authorization.Explore more
Sepset Biosciences's Social MediaPopular SearchesSepset Biosciences IncSepset BiosciencesSIC Code 87,873NAICS Code 54,541Show more

Is Sepset Biosciences your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Sepset Biosciences

Compare insights from companies similar to Sepset Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Sepset Biosciences

<$5M
11-50
Private
-
2016
N/A
$6.6M
11-50
Private
$43M
2014
<$5M
11-50
Private
-
2008
N/A
<$5M
1-10
Private
-
2013
JM
Jean MamelonaFounder & Director, Research & Development
<$5M
11-50
Private
-
2018
MB
Mark BazettSenior Director, Preclinical Development
<$5M
1-10
Private
-
2011
N/A
<$5M
1-10
Private
<$5M
2013
Kaley Wilson, Interim Chief Executive Officer, Sitka Biopharma at Sitka Biopharma
Kaley WilsonInterim CEO, Sitka Biopharma
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Sepset Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Sepset Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sepset Biosciences.

Sepset Biosciences Tech Stack

A closer look at the technologies used by Sepset Biosciences

Sepset Biosciences News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Sepset Biosciences

What is Sepset Biosciences's official website?
Sepset Biosciences's official website is www.sepset.ca
What is Sepset Biosciences's Revenue?
Sepset Biosciences's revenue is <$5 Million
What is Sepset Biosciences's SIC code?
Sepset Biosciences's SIC: 87,873
What is Sepset Biosciences's NAICS code?
Sepset Biosciences's NAICS: 54,541
How many employees does Sepset Biosciences have?
Sepset Biosciences has 11-50 employees
What industry does Sepset Biosciences belong to?
Sepset Biosciences is in the industry of: Business Services, Research & Development
What is Sepset Biosciences competition?
Sepset Biosciences top competitors include: Bold Therapeutics, Sitka Biopharma, Zucara Therapeutics, Biopaqc
What technology does Sepset Biosciences use?
Some of the popular technologies that Sepset Biosciences uses are: WordPress.org, reCAPTCHA, Squarespace Online Stores, Adobe Typekit
How do I contact Sepset Biosciences?
Sepset Biosciences contact info: Phone number: (778) 846-5406 Website: www.sepset.ca
What does Sepset Biosciences do?

Sepset Biosciences Inc. is a molecular diagnostics company focused on developing a first-in-class diagnostic assay for the early and rapid risk assessment of sepsis. Their innovative assay detects a unique sepsis gene expression signature linked to dysfunctional immune responses, rather than relying on pathogen presence. This technology addresses t... he significant challenges in current sepsis diagnosis methods, which are often slow and inaccurate, and targets a condition that affects over 49 million people globally each year. With the high costs associated with sepsis treatment, their solution has substantial commercial potential, although it has not yet received marketing authorization.Read More

What are Sepset Biosciences social media links?
Sepset Biosciences Twitter page
Is Sepset Biosciences a public company?
Sepset Biosciences is private company therefore does not currently have an official ticker symbol
See more information about Sepset Biosciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.